Table 6.
Comparative results of adaptive immunocytes related to immunosuppression (CD4+)
| Variable | Times | CG | EG | Z |
|---|---|---|---|---|
| CD4+CD25+T cells (%) | Baseline | 13.77 ± 2.10 | 13.47 ± 2.84 | -0.561 |
| Week 12 | 21.50 ± 5.02 | 11.68 ± 4.78 | -2.402# | |
| Z | -1.992* | -1.572 | ||
| CD4+CD25+T (cells/μL) | Baseline | 245.17 ± 21.38 | 232.50 ± 23.42 | -1.125 |
| Week 12 | 354.50 ± 123.20 | 154.08 ± 30.44 | -2.887## | |
| Z | -1.577 | -2.201* | ||
| CD4+CTLA-4+T cells (%) | Baseline | 21.13 ± 8.69 | 23.67 ± 7.87 | -0.641 |
| Week 12 | 23.10 ± 9.10 | 12.90 ± 3.60 | -1.922 | |
| Z | -0.314 | -2.201* | ||
| CD4+CTLA-4+T (cells/μL) | Baseline | 84.50 ± 11.33 | 87.40 ± 8.14 | -0.241 |
| Week 12 | 109.57 ± 41.83 | 72.57 ± 22.48 | -1.441 | |
| Z | -1.363 | -1.363 | ||
| CD4+PD-1+T cells (%) | Baseline | 33.52 ± 2.84 | 32.80 ± 7.17 | -0.480 |
| Week 12 | 39.87 ± 1.75 | 21.47 ± 6.92 | -2.882## | |
| Z | -2.201* | -2.207* | ||
| CD4+PD-1+T cells (cells/μL) | Baseline | 163.72 ± 45.76 | 164.50 ± 79.63 | -0.320 |
| Week 12 | 182.00 ± 17.37 | 112.50 ± 40.38 | -2.246# | |
| Z | -0.943 | -2.201* |
Values are presented as mean±standard deviation. The data in the groups were analyzed by Mann–Whitney U-test, while those in the times were analyzed by Wilcoxon signed-rank test.
CG, control group; EG, exercise group.
*
P≤0.05 when compared to baseline at week 12.
#
P≤0.05 and ##P≤0.01 respectively when compared to EG at CG.